Advertisement
Advertisement
Advanced therapies · health · Emerging
Lab-Grown Human Gut Cells Reveal How Fat Triggers Fullness Hormone
Lab-grown gut cellsFat sensor foundAppetite hormone CCKNo human dosing yet
Researchers engineered human intestinal organoids, lab-grown clusters of gut cells, to pinpoint how fat triggers release of cholecystokinin (CCK), a hormone involved in fullness signaling, according to a study published in Molecular Metabolism. The work, done in human duodenal organoids, identifies a receptor called FFAR1 as the key switch, while a related receptor, FFAR4, turned out not to matter for this response.
Using CRISPR gene-editing, researchers built human duodenal organoids, small lab-grown clusters of gut lining cells, with built-in glowing markers at the CCK gene, letting them sort and study CCK-producing cells directly. Sample size was not reported. Gene activity scans found several lipid-sensing receptors on these cells, including FFAR1, FFAR4, FFAR2, GPR119, GPBAR1 and two smell-related receptors, OR51E1 and OR51E2. Fatty acids and drugs that activate FFAR1 raised calcium levels inside the cells, while drugs targeting GPBAR1 and GPR119, along with short-chain fatty acids, raised a separate signaling molecule called cAMP. CCK was released in response to FFAR1, GPBAR and GPR119 activation, and in response to fatty acids with chains longer than 8 carbons, measured directly in these engineered cells. When researchers deleted the FFAR1 gene, the cells lost their calcium and CCK response to fatty acids. Deleting FFAR4 instead left the response unchanged, matching normal cells.
CCK is a hormone released by specialized gut cells called I-cells after eating fat; established physiology holds that it slows stomach emptying and signals the brain that a meal has arrived, part of how fullness develops. The authors conclude that FFAR1 plays a central role in triggering this fat-driven CCK release in their organoid model, while FFAR4 appears redundant for this particular job, even though earlier research has linked FFAR4 to fat sensing elsewhere in the body. The findings identify FFAR1 as a specific molecular target worth exploring in future drug research aimed at appetite and metabolic regulation; the chain-length finding describes how these lab-grown cells responded to specific fatty acid structures, not a conclusion about which foods people should eat.
In human I-cells, FFAR1 plays a crucial role in lipid-induced CCK release, whereas FFAR4 appears to be redundant in this context
Data Panel
- Who
- Human duodenal organoids (lab-grown gut cell clusters); sample size not reported
- Design
- CRISPR-engineered organoids with fluorescent and cAMP reporters inserted at the CCK gene; cells sorted and profiled, tested with live-cell imaging and LC-MS/MS hormone measurement; FFAR1, FFAR4 and GPR119 gene-knockout organoids generated
- Dose
- Not applicable; lab exposure to fatty acids and receptor-specific agonist compounds, concentrations not reported in abstract
- Primary result
- Deleting FFAR1 eliminated the calcium and CCK secretion response to fatty acids; deleting FFAR4 left responses unchanged compared with normal cells
- Secondary
- CCK release was triggered by agonists of FFAR1, GPBAR1 and GPR119, and by fatty acids with chain length greater than 8 carbons; GPBAR1 and GPR119 agonists and short-chain fatty acids raised cAMP levels
- Funding / conflicts
- Not reported in the available abstract
This was lab-dish work on engineered human gut organoids, not a human trial, sample size was not reported, and no dosing or weight, appetite or metabolic outcomes in living people were measured. Funding and conflicts were not reported in the available abstract.
Dr. Axe's Take
I find this receptor-level mapping valuable because it shows a specific molecular doorway, FFAR1, that human gut cells use to sense fat and signal fullness through CCK. This is organoid work in a dish, not a feeding study in people, and nobody has shown eating any particular fat activates this pathway the same way in a living gut. My view is this mechanism is promising but unproven as dietary guidance right now. I would watch for human follow-up studies before drawing food conclusions. This week, my practical step is paying attention to how satisfied a meal with adequate fat and protein leaves you, without assuming it works through this exact pathway.
— Dr. Axe